These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2153353)

  • 41. Paradoxic effect of ibuprofen on neutrophil accumulation in pulmonary and cutaneous inflammation.
    Hellewell PG; Young SK; Henson PM; Worthen GS
    Am J Respir Crit Care Med; 1995 Apr; 151(4):1218-27. PubMed ID: 7697256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats.
    Johansen HK; Hougen HP; Rygaard J; Høiby N
    Clin Exp Immunol; 1996 Feb; 103(2):212-8. PubMed ID: 8565302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Airway inflammation in cystic fibrosis.
    Elizur A; Cannon CL; Ferkol TW
    Chest; 2008 Feb; 133(2):489-95. PubMed ID: 18252915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphological and immunohistochemical studies of the lungs and bronchus-associated lymphoid tissue in a rat model of chronic pulmonary infection with Pseudomonas aeruginosa.
    Iwata M; Sato A
    Infect Immun; 1991 Apr; 59(4):1514-20. PubMed ID: 2004830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia.
    Graham LM; Vasil A; Vasil ML; Voelkel NF; Stenmark KR
    Am Rev Respir Dis; 1990 Jul; 142(1):221-9. PubMed ID: 2368972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of Ibuprofen in children with cystic fibrosis.
    Han EE; Beringer PM; Louie SG; Gill MA; Shapiro BJ
    Clin Pharmacokinet; 2004; 43(3):145-56. PubMed ID: 14871154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapies aimed at airway inflammation in cystic fibrosis.
    Konstan MW
    Clin Chest Med; 1998 Sep; 19(3):505-13, vi. PubMed ID: 9759552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lung infection caused by Pseudomonas aeruginosa in a CD26/DPP4 deficient F344 rat model.
    Neuhaus M; Munder A; Schipke J; Schmiedl A
    Inflamm Res; 2019 Jul; 68(7):529-544. PubMed ID: 31089745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ibuprofen attenuates hypochlorous acid production from neutrophils in porcine acute lung injury.
    Carey PD; Byrne K; Jenkins JK; Sielaff TD; Walsh CJ; Fowler AA; Sugerman HJ
    J Surg Res; 1990 Sep; 49(3):262-70. PubMed ID: 2168503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects.
    Konstan MW; Hoppel CL; Chai BL; Davis PB
    J Pediatr; 1991 Jun; 118(6):956-64. PubMed ID: 2040934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammation and cystic fibrosis pulmonary disease.
    Kennedy MJ
    Pharmacotherapy; 2001 May; 21(5):593-603. PubMed ID: 11349748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis.
    Konstan MW; Davis PB
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1409-23. PubMed ID: 12458152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exogenous rh-urokinase modifies inflammation and Pseudomonas aeruginosa infection in a rat chronic pulmonary infection model.
    Hart DA; Green F; Whidden P; Henkin J; Woods DE
    Can J Microbiol; 1993 Dec; 39(12):1127-34. PubMed ID: 8131109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary cellular response to chronic irritation and chronic Pseudomonas aeruginosa pneumonia in cats.
    Thomassen MJ; Klinger JD; Winnie GB; Wood RE; Burtner C; Tomashefski JF; Horowitz JG; Tandler B
    Infect Immun; 1984 Sep; 45(3):741-7. PubMed ID: 6432697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Piroxicam treatment protects mice from lethal pulmonary challenge with Pseudomonas aeruginosa.
    Sordelli DO; Cerquetti MC; Fontán PA; Meiss RP
    J Infect Dis; 1989 Feb; 159(2):232-8. PubMed ID: 2915154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pseudomonas aeruginosa pneumonia. Treatment with nonsteroidal anti-inflammatory agents to prevent lung tissue damage.
    Sordelli DO; Cerquetti MC; Fontán PA; García VE
    Antibiot Chemother (1971); 1989; 42():247-53. PubMed ID: 2596837
    [No Abstract]   [Full Text] [Related]  

  • 57. High-Dose Ibuprofen in Cystic Fibrosis.
    Lands LC; Dauletbaev N
    Pharmaceuticals (Basel); 2010 Jul; 3(7):2213-2224. PubMed ID: 27713350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-dependent pharmacokinetics of ibuprofen in the rat.
    Shah A; Jung D
    Drug Metab Dispos; 1987; 15(2):151-4. PubMed ID: 2882970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic Antimicrobial Effects of Ibuprofen Combined with Standard-of-Care Antibiotics against Cystic Fibrosis Pathogens.
    Chen Q; Ilanga M; Simbassa SB; Chirra B; Shah KN; Cannon CL
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis.
    Elborn JS; Konstan MW; Taylor-Cousar JL; Fajac I; Horsley A; Sutharsan S; Aaron SD; Daines CL; Uluer A; Downey DG; Lucidi VV; Ahuja S; Springman E; Mershon J; Grosswald R; Rowe SM;
    J Cyst Fibros; 2021 Nov; 20(6):1026-1034. PubMed ID: 34538755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.